GGrantIndex
← Leaderboards

Andrew Abba Stolz

University Of Southern California

$9,063,253
Attributed
$9,961,280
Total exposure
4
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $887.1K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,961,280 · 4

By mechanism

U01$6,947,967 · 2
P30$1,807,578 · 1
R01$1,205,735 · 1

Top collaborators

Most similar at University Of Southern California

Same institution · by research overlap

Others in their field

Top investigators on “Future

Research focus

FutureUnited StatesCountyLos AngelesResponsePopulation HeterogeneityResearch PersonnelResourcesPharmaceutical PreparationsEnrollmentFollow-UpScientific Advances And AccomplishmentsEtiologyEventCollectionTalentsLiver InjuryResearch Clinical TestingMedical SchoolsPatient PopulationSpecimenDatabasesEthnic DiversityBase

Grant awards (34)

USC Cirrhosis Clinical Center$396,266
U01 · FY2025 · DK
USC-UCLA Drug-Induced Liver Injury (DILI) Clinical Center$346,560
U01 · FY2024 · DK · contact PI
USC Cirrhosis Clinical Center$82,287
U01 · FY2024 · DK
USC Cirrhosis Clinical Center$524,271
U01 · FY2023 · DK
USC-UCLA Drug-Induced Liver Injury (DILI) Clinical Center$362,836
U01 · FY2023 · DK · contact PI
USC Cirrhosis Clinical Center$470,375
U01 · FY2022 · DK
USC-UCLA Drug-Induced Liver Injury (DILI) Clinical Center.$280,240
U01 · FY2022 · DK · contact PI
USC Cirrhosis Clinical Center$322,855
U01 · FY2021 · DK
USC-UCLA Drug-Induced Liver Injury (DILI) Clinical Center.$288,032
U01 · FY2021 · DK · contact PI
USC-UCLA Drug-Induced Liver Injury (DILI) Clinical Center.$351,888
U01 · FY2020 · DK · contact PI
USC-UCLA Drug-Induced Liver Injury (DILI) Clinical Center.$353,032
U01 · FY2019 · DK · contact PI
USC-UCLA Drug-Induced Liver Injury (DILI) Clinical Center.$398,489
U01 · FY2018 · DK · contact PI
USC-UCLA Drug-Induced Liver Injury (DILI) Clinical Center.$312,550
U01 · FY2017 · DK · contact PI
USC-UCLA Drug-Induced Liver Injury (DILI) Clinical Center.$289,155
U01 · FY2016 · DK · contact PI
USC-UCLA Drug-Induced Liver Injury (DILI) Clinical Center.$330,732
U01 · FY2015 · DK · contact PI
USC-UCLA Drug-Induced Liver Injury (DILI) Clinical Center.$334,892
U01 · FY2014 · DK · contact PI
USC-UCLA Drug-Induced Liver Injury (DILI) Clinical Center.$337,075
U01 · FY2013 · DK · contact PI
USC-UCLA Drug-Induced Liver Injjry (DILI) Clinical Center$258,628
U01 · FY2012 · DK · contact PI
Targeting DHT Catabolism by AKR1Cs for Prostrate Cancer Prevention and Treatment.$293,460
R01 · FY2011 · CA · contact PI
USC-UCLA Drug-Induced Liver Injjry (DILI) Clinical Center$264,806
U01 · FY2011 · DK · contact PI
Targeting DHT Catabolism by AKR1Cs for Prostrate Cancer Prevention and Treatment.$303,469
R01 · FY2010 · CA · contact PI
USC-UCLA Drug-Induced Liver Injjry (DILI) Clinical Center$132,140
U01 · FY2010 · DK · contact PI
Targeting DHT Catabolism by AKR1Cs for Prostrate Cancer Prevention and Treatment.$304,403
R01 · FY2009 · CA · contact PI
USC-UCLA Drug-Induced Liver Injjry (DILI) Clinical Center$247,311
U01 · FY2009 · DK · contact PI
CORE--MOLECULAR BIOLOGY$233,753
P30 · FY2009 · DK · contact PI
Targeting DHT Catabolism by AKR1Cs for Prostrate Cancer Prevention and Treatment.$304,403
R01 · FY2008 · CA · contact PI
USC-UCLA Drug-Induced Liver Injjry (DILI) Clinical Center$263,547
U01 · FY2008 · DK · contact PI
CORE--MOLECULAR BIOLOGY$231,628
P30 · FY2008 · DK · contact PI
CORE--MOLECULAR BIOLOGY$229,585
P30 · FY2007 · DK · contact PI
CORE--MOLECULAR BIOLOGY$241,309
P30 · FY2006 · DK · contact PI
CORE--MOLECULAR BIOLOGY$233,803
P30 · FY2005 · DK
CORE--MOLECULAR BIOLOGY FACILITY$212,500
P30 · FY2002 · DK
CORE--MOLECULAR BIOLOGY FACILITY$212,500
P30 · FY2001 · DK
CORE--MOLECULAR BIOLOGY FACILITY$212,500
P30 · FY2000 · DK